Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
Der Internist
|
January 31, 2020
[Medicinal treatment of pancreatic cancer : Still a domain of chemotherapy?]
Georg Feldmann
Oncology Research and Treatment
|
October 1, 2018
Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts
Savita Bisht, Georg Feldmann
Expert Opinion on Drug Discovery
|
January 19, 2019
Animal models for modeling pancreatic cancer and novel drug discovery
Savita Bisht, Georg Feldmann
The Journal of Molecular Diagnostics : JMD
|
February 9, 2008
Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts
Georg Feldmann, Anirban Maitra
Expert Opinion on Drug Discovery
|
February 18, 2010
In vitro models of pancreatic cancer for translational oncology research
Georg Feldmann, Sherri Rauenzahn, Anirban Maitra
Expert Opinion on Drug Metabolism & Toxicology
|
April 18, 2013
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors
Savita Bisht, Georg Feldmann, Peter Brossart
Deutsche Medizinische Wochenschrift (1946)
|
March 6, 2019
[Leukemia caused by collision with a wild pig?]
Maximilian Zimmermann, Gerd Bendas, Georg Feldmann
Oncology Research and Treatment
|
October 5, 2018
Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma
Savita Bisht, Peter Brossart, Georg Feldmann
Current Opinion in Investigational Drugs (London, England : 2000)
|
December 15, 2010
Agents targeting the Hedgehog pathway for pancreatic cancer treatment
Savita Bisht, Peter Brossart, Anirban Maitra, et al.
Expert Opinion on Drug Discovery
|
June 1, 2012
Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research
Ute Schütte, Savita Bisht, Peter Brossart, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
Der Internist
|
January 31, 2020
[Medicinal treatment of pancreatic cancer : Still a domain of chemotherapy?]
Georg Feldmann
Oncology Research and Treatment
|
October 1, 2018
Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts
Savita Bisht, Georg Feldmann
Expert Opinion on Drug Discovery
|
January 19, 2019
Animal models for modeling pancreatic cancer and novel drug discovery
Savita Bisht, Georg Feldmann
The Journal of Molecular Diagnostics : JMD
|
February 9, 2008
Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts
Georg Feldmann, Anirban Maitra
Expert Opinion on Drug Discovery
|
February 18, 2010
In vitro models of pancreatic cancer for translational oncology research
Georg Feldmann, Sherri Rauenzahn, Anirban Maitra
Expert Opinion on Drug Metabolism & Toxicology
|
April 18, 2013
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors
Savita Bisht, Georg Feldmann, Peter Brossart
Deutsche Medizinische Wochenschrift (1946)
|
March 6, 2019
[Leukemia caused by collision with a wild pig?]
Maximilian Zimmermann, Gerd Bendas, Georg Feldmann
Oncology Research and Treatment
|
October 5, 2018
Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma
Savita Bisht, Peter Brossart, Georg Feldmann
Current Opinion in Investigational Drugs (London, England : 2000)
|
December 15, 2010
Agents targeting the Hedgehog pathway for pancreatic cancer treatment
Savita Bisht, Peter Brossart, Anirban Maitra, et al.
Expert Opinion on Drug Discovery
|
June 1, 2012
Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research
Ute Schütte, Savita Bisht, Peter Brossart, et al.
Page
of 10